OCUL: Ocular Therapeutix, Inc. Company Profile & Statistics

Ocular Therapeutix, Inc. Profile

About

Ocular Therapeutix, Inc. is a biopharmaceutical company. It is focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. The Company develops and markets eye care products. Ocular Therapeutix, Inc. is headquartered in Bedford, Massachusetts.

Info & Links

CEO

Pravin Dugel

Headquarters

15 CROSBY DRIVE
BEDFORD, MA 01730, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

274

Ocular Therapeutix, Inc. Statistics

Valuation Measures

Market Capitalization²

3.02B

Enterprise Value

2.74B

Enterprise Value/EBITDA(ttm)

-11.12

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

55.61

Price to Book(mrq)

9.81

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

88.59%

Operating Margin(ttm)

-443.15%

Profit Margin(ttm)

-465.79%

Return on Equity(ttm)

-86.33%

Return on Invested Capital(ttm)

-70.87%

Return on Assets(ttm)

-57.29%

Income Statement

Revenue(ttm)

55.78M

Revenue Per Share(ttm)

0.26

Gross Profit(ttm)

49.57M

EBITDA(ttm)³

-246.81M

Net Income Available to Common(ttm)

-249.67M

Diluted EPS(ttm)

-1.44

Share Statistics

Beta (5Y Monthly)

0.96

52-Week Change

63.06%

S&P 500 52-Week Change

12.22%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

213.05M

Dividend Yield

0.00%

Float⁴

208.15M

% Held by Insiders

2.30%

% Held by Institutions

59.21%

Balance Sheet

Total Cash(mrq)

344.77M

Total Cash Per Share(mrq)

1.62

Total Debt(mrq)

70.62M

Total Debt/Equity(mrq)

27.35%

Current Ratio(mrq)

7.85%

Quick Ratio(mrq)

7.78%

Book Value Per Share(mrq)

1.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.82

Free Cash Flow(ytd)

-159.68M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

OCUL

Ocular Therapeutix, Inc.